<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OPINION STATEMENT: Atrial and <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> commonly arise in the setting of cardiogenic shock and often result in hemodynamic deterioration </plain></SENT>
<SENT sid="1" pm="."><plain>Causative factors include <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">myocardial ischemia</z:e>, volume overload, and metabolic disturbances </plain></SENT>
<SENT sid="2" pm="."><plain>Correcting these factors plays an important role in managing <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> in this setting </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0004308'>Ventricular arrhythmias</z:hpo> are more ominous compared to atrial <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> but both require prompt intervention with electrical shock and anti-arrhythmic drug suppression </plain></SENT>
<SENT sid="4" pm="."><plain>Coronary reperfusion is key to improving survival, including reducing the risk of sudden <z:hpo ids='HP_0001695'>cardiac arrest</z:hpo>, in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Case series have also demonstrated the value of intra-aortic balloon pump counter-pulsation in suppressing <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> in cardiogenic shock </plain></SENT>
<SENT sid="6" pm="."><plain>The mechanism of <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> suppression may be due to improved coronary perfusion and afterload reduction </plain></SENT>
<SENT sid="7" pm="."><plain>Percutaneous ventricular assist device placement may be effective in this setting; however, data addressing this specific endpoint are lacking </plain></SENT>
<SENT sid="8" pm="."><plain>Anti-arrhythmic drug options for ventricular and atrial <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> suppression, in the setting of cardiogenic shock, are relatively limited </plain></SENT>
<SENT sid="9" pm="."><plain>Common class I agents are excluded due to the inherent abnormal cardiac structure and function in the setting of cardiogenic shock </plain></SENT>
<SENT sid="10" pm="."><plain>Class III drug options include <z:chebi fb="0" ids="4681">dofetilide</z:chebi> and <z:chebi fb="0" ids="2663">amiodarone</z:chebi> </plain></SENT>
<SENT sid="11" pm="."><plain>The other Class III agents, sotalol and <z:chebi fb="0" ids="50659">dronedarone</z:chebi>, are excluded due to associated mortality observed in the SWORD and ANDROMEDA trials, respectively </plain></SENT>
<SENT sid="12" pm="."><plain><z:chebi fb="0" ids="4681">Dofetilide</z:chebi> is renally excreted and causes QT interval prolongation </plain></SENT>
<SENT sid="13" pm="."><plain>Care should be taken to avoid excessive drug accumulation due to poor kidney perfusion and function </plain></SENT>
<SENT sid="14" pm="."><plain><z:chebi fb="0" ids="4681">Dofetilide</z:chebi> is approved for use for atrial <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> and has not been studied for <z:hpo ids='HP_0004308'>ventricular arrhythmia</z:hpo> suppression </plain></SENT>
<SENT sid="15" pm="."><plain>The DIAMOND-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CHF</z:e> trial established its safety in the setting of <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="16" pm="."><plain><z:chebi fb="0" ids="2663">Amiodarone</z:chebi> is very effective in suppressing both atrial and <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> </plain></SENT>
<SENT sid="17" pm="."><plain>It is often the drug of choice in <z:hpo ids='HP_0001635'>heart failure</z:hpo> </plain></SENT>
<SENT sid="18" pm="."><plain>Its off-label use for atrial <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> is very common </plain></SENT>
<SENT sid="19" pm="."><plain>Care should be taken with intravenous <z:chebi fb="0" ids="2663">amiodarone</z:chebi> to avoid <z:hpo ids='HP_0002615'>hypotension</z:hpo> </plain></SENT>
</text></document>